Cooley LLP is highly recommended for its overseeing of transactional work in the biopharmaceuticals space, regularly assisting Chinese companies in their operations and commercial deals abroad. Central to the team is Yuming Liu, who specialises in private financings, M&A, joint ventures, and corporate partnering and licensing in the life sciences, healthcare, and technology sectors. Christina Zhang is also integral; an expert in cross border financings who counts a number of innovative companies in the life sciences space among her clients. Further key names include Patrick Loofbourrow, who specialises in work for emerging companies in the medical field, and the public-private mergers-focused Ruomu Li, who joined from Morrison Foerster in December 2022.
Key clients
- Asymchem Laboratories
- Eight Roads Capital
Work highlights
- Advised Summit Healthcare Acquisition Corp. on its de-SPAC transaction with Yisehng Bio, which valued YS Biopharma at an implied enterprise value of US$849 million and delivered approximately US$36 million of gross proceeds.
- Advised Zion Biopharma on Roche’s acquisition of the global rights to Zion’s ZN-A-1041.